These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2479227)

  • 1. Melperone in the treatment of schizophrenia.
    Bjerkenstedt L
    Acta Psychiatr Scand Suppl; 1989; 352():35-9. PubMed ID: 2479227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene.
    Bjerkenstedt L; Gullberg B; Härnryd C; Sedvall G
    Arch Psychiatr Nervenkr (1970); 1977 Oct; 224(2):107-18. PubMed ID: 21644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women.
    Bjerkenstedt L; Gullberg B; Härnryd C; Sedvall G
    Arch Psychiatr Nervenkr (1970); 1979; 227(3):181-92. PubMed ID: 94992
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS.
    Bjerkenstedt L; Härnryd C; Grimm V; Gullberg B; Sedvall G
    Arch Psychiatr Nervenkr (1970); 1978 Dec; 226(3):157-72. PubMed ID: 32861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward.
    Härnryd C; Bjerkenstedt L; Gullberg B
    Acta Psychiatr Scand Suppl; 1989; 352():40-7. PubMed ID: 2573240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
    Alfredsson G; Bjerkenstedt L; Edman G; Härnryd C; Oxenstierna G; Sedvall G; Wiesel FA
    Acta Psychiatr Scand Suppl; 1984; 311():49-74. PubMed ID: 6199949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia.
    Sumiyoshi T; Jayathilake K; Meltzer HY
    Schizophr Res; 2003 Jul; 62(1-2):65-72. PubMed ID: 12765745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women.
    Bjerkenstedt L; Eneroth P; Härnryd C; Sedvall G
    Arch Psychiatr Nervenkr (1970); 1977 Dec; 224(4):281-93. PubMed ID: 343747
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of melperone, two of its metabolites and thiothixene on central monoamine metabolism and prolactin levels in rodents.
    Wiesel FA; Bjerkenstedt L; Skett P
    Acta Pharmacol Toxicol (Copenh); 1978 Aug; 43(2):129-36. PubMed ID: 696342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-hydroxybutyrate in the treatment of schizophrenia.
    Levy MI; Davis BM; Mohs RC; Trigos GC; Mathé AA; Davis KL
    Psychiatry Res; 1983 May; 9(1):1-8. PubMed ID: 6193548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF; Waldmeier P; Beckmann H
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates.
    Breslin NA; Suddath RL; Bissette G; Nemeroff CB; Lowrimore P; Weinberger DR
    Schizophr Res; 1994 Apr; 12(1):35-41. PubMed ID: 7517175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine treatment of schizophrenia: can we predict treatment response?
    van Kammen DP; Peters JL; van Kammen WB; Rosen J; Yao JK; McAdam D; Linnoila M
    Psychiatry Res; 1989 Mar; 27(3):297-311. PubMed ID: 2469097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of raclopride treatment on plasma and CSF HVA: relationships with clinical improvement in male schizophrenics.
    Csernansky JG; Newcomer JW; Jackson K; Lombrozo L; Faull KF; Zipursky R; Pfefferbaum A; Faustman WO
    Psychopharmacology (Berl); 1994 Nov; 116(3):291-6. PubMed ID: 7534423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
    Pickar D; Breier A; Hsiao JK; Doran AR; Wolkowitz OM; Pato CN; Konicki PE; Potter WZ
    Arch Gen Psychiatry; 1990 Jul; 47(7):641-8. PubMed ID: 1694425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment.
    Härnryd C; Bjerkenstedt L; Grimm VE; Sedvall G
    Psychopharmacology (Berl); 1979 Aug; 64(2):131-4. PubMed ID: 115032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.